Epithalon

A research peptide that inhibits connective tissue growth factor (CCN2/CTGF), a key mediator of tissue fibrosis. Targets the fundamental fibrotic pathway involved in organ aging and disease.

A naturally occurring dipeptide (beta-alanine + histidine) with potent anti-glycation, antioxidant, and pH-buffering properties. Acts as an AGE inhibitor, preventing cross-linking of proteins that accelerates tissue aging.

Cortagen is a short synthetic bioregulator peptide developed by Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology. It is designed to target the adrenal cortex, supporting the regulation of cortisol production and adrenal gland function. Bioregulator peptides are based on the concept that short peptide sequences derived from or mimicking endogenous tissue-specific peptides can restore gene expression patterns in aging or damaged tissues. Cortagen is proposed to normalise adrenal cortex function by interacting with DNA and modulating transcription of genes involved in steroidogenesis. While the bioregulator concept has theoretical appeal, the evidence base consists primarily of preclinical studies and observational reports from Russian clinical practice.